---
title: "BTIG Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG)"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/268473187.md"
description: "BTIG analyst Justin Zelin maintained a Buy rating for Ascentage Pharma Group International Unsponsored ADR, setting a price target of $50.00. Zelin, a 4-star analyst with an 8.0% average return, focuses on the Healthcare sector. The analyst consensus for Ascentage Pharma is Strong Buy, with a price target consensus of $49.67."
datetime: "2025-12-03T17:27:32.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268473187.md)
  - [en](https://longbridge.com/en/news/268473187.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268473187.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/268473187.md) | [繁體中文](https://longbridge.com/zh-HK/news/268473187.md)


# BTIG Sticks to Their Buy Rating for Ascentage Pharma Group International Unsponsored ADR (AAPG)

BTIG analyst Justin Zelin maintained a Buy rating on Ascentage Pharma Group International Unsponsored ADR yesterday and set a price target of $50.00.

### TipRanks Cyber Monday Sale

-   Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
-   Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off

According to TipRanks, Zelin is a 4-star analyst with an average return of 8.0% and a 38.08% success rate. Zelin covers the Healthcare sector, focusing on stocks such as NovaBridge Biosciences, Viking Therapeutics, and IDEAYA Biosciences.

Ascentage Pharma Group International Unsponsored ADR has an analyst consensus of Strong Buy, with a price target consensus of $49.67.

### 相关股票

- [Ascentage Pharma (AAPG.US)](https://longbridge.com/zh-CN/quote/AAPG.US.md)
- [ASCENTAGE-B (06855.HK)](https://longbridge.com/zh-CN/quote/06855.HK.md)

## 相关资讯与研究

- [LifeSci Capital Keeps Their Buy Rating on Enliven Therapeutics (ELVN)](https://longbridge.com/zh-CN/news/280882703.md)
- [Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields](https://longbridge.com/zh-CN/news/281183048.md)
- [Pyxis Oncology (PYXS) Receives a Rating Update from a Top Analyst](https://longbridge.com/zh-CN/news/280883162.md)
- [Idorsia Ltd (IDIA) Receives a Rating Update from a Top Analyst](https://longbridge.com/zh-CN/news/281283879.md)
- [China Tianbao Narrows Annual Loss but Keeps Dividend on Hold](https://longbridge.com/zh-CN/news/281267546.md)